Immunity's core reset: Synbiotics and gut microbiota in the COVID-19 era
Dejana Bajić, Nemanja Todorović, Mladena Lalić Popović, Milica Plazačić, Andrea Mihajlović
Innate Immunity, doi:10.1177/17534259251362023
The gut microbiome plays a crucial role in shaping immune responses, and its connection to immunity has never been more relevant than in the COVID-19 era. The interaction between gut microbes and the immune system, known as microbiome-immunity crosstalk, influences both how the body responds to infections and how well it recovers. COVID-19, whether in its acute phase or lingering as long COVID, has been linked to disturbances in the gut microbiome. During infection, many patients experience dysbiosis-an imbalance in gut bacteria-that can contribute to immune dysfunction and excessive inflammation. This imbalance may not only worsen the severity of the disease but also prolong recovery, leading to persistent symptoms like fatigue, brain fog, and digestive issues. Long COVID, in particular, has been associated with ongoing immune dysregulation, where the body's defense system remains in a state of heightened activation, causing chronic inflammation. Given the strong link between gut health and immunity, there is growing interest in strategies to restore microbial balance. Synbiotics-combinations of probiotics (beneficial bacteria) and prebiotics (nutrients that support them)-are being explored as a potential therapeutic approach. By replenishing beneficial gut microbes, synbiotics may help regulate immune responses, reduce inflammation, and support overall recovery from COVID-19. Emerging research suggests that improving gut health could enhance the body's ability to fight infections and recover more efficiently. As we continue to understand the long-term impact of COVID-19, focusing on the gut microbiome offers a promising path forward. Supporting a balanced and diverse microbiome through diet, lifestyle, and targeted interventions like synbiotics may provide a natural way to strengthen immunity and improve health outcomes in both acute and long COVID cases.
Declaration of conflicting interests The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
Ailioaie, Ailioaie, Litscher, Gut Microbiota and mitochondria: health and pathophysiological aspects of long COVID, Int J Mol Sci
Alenazy, Aljohar, Alruwaili, Gut Microbiota dynamics in relation to long-COVID-19 syndrome: role of probiotics to combat psychiatric complications, Metabolites
Bohmwald, Diethelm-Varela, Rodríguez-Guilarte, Pathophysiological, immunological, and inflammatory features of long COVID, Front Immunol
Brodin, Immune determinants of COVID-19 disease presentation and severity, Nat Med
Davis, Mccorkell, Vogel, Long COVID: major findings, mechanisms and recommendations, Nat Rev Microbiol
Dodero, Morré, Behzadi, Editorial: gut microbiota and immunity in health and disease: dysbiosis and eubiosis's effects on the human body, Front Immunol
Emadzadeh, Kabiri, Assessment of the prophylactic effects of probiotics, prebiotics, and synbiotics against COVID-19 infection: a systematic review of randomized controlled trials, Clin Med Res
García, Immune response, inflammation, and the clinical Spectrum of COVID-19, Front Immunol
Ghanbari, Hasani, Aghili, The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: a review, Food Sci Nutr
Giancola, Fontana, Panebianco, Efficacy of a multistrain synbiotic treatment in acute and post-acute COVID-19 patients: a double-blind, placebo-controlled randomized trial, Microorganisms
Gorman, Syed, Connecting the dots in emerging mast cell research: do factors affecting mast cell activation provide a missing link between adverse COVID-19 outcomes and the social determinants of health?, Med Sci
Guo, Tang, Zhang, COVID-19: from immune response to clinical intervention, Precis Clin Med
Gámez-Macías, Félix-Soriano, Samblas, Intestinal permeability, gut inflammation, and gut immune system response are linked to aging-related changes in gut Microbiota composition: a study in female mice, J Gerontol -Ser A Biol Sci Med Sci
Han, Xu, Xie, Engineering strategies to modulate the gut microbiome and immune system, J Immunol
Khan, Petersen, Shekhar, Commensal bacteria: an emerging player in defense against respiratory pathogens, Front Immunol
Krishnamurthy, Pereira, Bosco, Gut commensals and their metabolites in health and disease, Front Microbiol
Li, Hu, Yin, Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial, Gut Microbes
Maftei, Raileanu, Balta, The potential impact of probiotics on human health: an update on their health-promoting properties, Microorganisms
Makhluf, Madany, Kim, Long COVID: long-term impact of SARS-CoV2, Diagnostics
Medina-Rodríguez, Martínez-Raga, Sanz, Intestinal barrier, immunity and microbiome: partners in the depression crime, Pharmacol Rev
Mounir, Ibijbijen, Farih, Synbiotics and their antioxidant properties, mechanisms, and benefits on human and animal health: a narrative review, Biomolecules
Mörbe, Jørgensen, Fenton, Human gut-associated lymphoid tissues (GALT); diversity, structure, and function, Mucosal Immunol
Pazukhina, Garcia-Gallo, Reyes, Long COVID: a global health issue -a prospective, cohort study set in four continents, BMJ Glob Heal
Peluso, Deeks, Mechanisms of long COVID and the path toward therapeutics, Cell
Phetsouphanh, Jacka, Ballouz, Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection, Nat Commun
Reza, Kheirandish, Ghiasi, Immunosenescence and inflamm-ageing in COVID-19, Ageing Res Rev
Robb, Goepp, Rossi, Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19, Br J Pharmacol
Sabit, Ghany, Abdallah, Vitamin D: a key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants, Inflammopharmacology
Sai, Shetty, Shetty, Hln, Influence of gut microbiota on autoimmunity: a narrative review, Brain Behav Immun Integr
Shu, Song, Zhang, Screen of propionateproducing probiotic strains in attenuating murine colitis by modulating immune response and restoring the intestinal barrier, J Funct Foods
Sumantri, Rengganis, Immunological dysfunction and mast cell activation syndrome in long COVID, Asia Pac Allergy
Takahashi, Ellingson, Wong, Sex differences in immune responses that underlie COVID-19 disease outcomes, Nature
Takeuchi, Nakanishi, Ohno, Microbial metabolites and gut immunology, Annu Rev Immunol
Trivedi, Abbas, Lehmann, Antiviral and antiinflammatory plant-derived bioactive compounds and their potential use in the treatment of COVID-19-related pathologies, J Xenobiotics
Ullah, Arbab, Tian, Crosstalk between gut microbiota and host immune system and its response to traumatic injury, Front Immunol
Vaezi, Ravanshad, Rad, The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID-19 patients: a randomized placebo-controlled trial, J Med Virol
Van Hul, Cani, Petifils, What defines a healthy gut microbiome?, Gut
Velikova, Kaouri, Bakopoulou, Mucosal immunity and trained innate immunity of the gut, Gastroenterol Insights
Yoo, Oh, Unconventional immune cells in the gut mucosal barrier: regulation by symbiotic microbiota, Exp Mol Med
Yu, Gastrointestinal pathophysiology in long COVID: exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms, Life Sci
Zhang, Xu, Mak, Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: an open-label pilot study, J Gastroenterol Hepatol
Zolghadrpour, Jowshan, Seyedmahalleh, Consumption of a new developed synbiotic yogurt improves oxidative stress status in adults with metabolic syndrome: a randomized controlled clinical trial, Sci Rep
DOI record:
{
"DOI": "10.1177/17534259251362023",
"ISSN": [
"1753-4259",
"1753-4267"
],
"URL": "http://dx.doi.org/10.1177/17534259251362023",
"abstract": "<jats:p>The gut microbiome plays a crucial role in shaping immune responses, and its connection to immunity has never been more relevant than in the COVID-19 era. The interaction between gut microbes and the immune system, known as microbiome-immunity crosstalk, influences both how the body responds to infections and how well it recovers. COVID-19, whether in its acute phase or lingering as long COVID, has been linked to disturbances in the gut microbiome. During infection, many patients experience dysbiosis—an imbalance in gut bacteria—that can contribute to immune dysfunction and excessive inflammation. This imbalance may not only worsen the severity of the disease but also prolong recovery, leading to persistent symptoms like fatigue, brain fog, and digestive issues. Long COVID, in particular, has been associated with ongoing immune dysregulation, where the body's defense system remains in a state of heightened activation, causing chronic inflammation. Given the strong link between gut health and immunity, there is growing interest in strategies to restore microbial balance. Synbiotics—combinations of probiotics (beneficial bacteria) and prebiotics (nutrients that support them)—are being explored as a potential therapeutic approach. By replenishing beneficial gut microbes, synbiotics may help regulate immune responses, reduce inflammation, and support overall recovery from COVID-19. Emerging research suggests that improving gut health could enhance the body's ability to fight infections and recover more efficiently. As we continue to understand the long-term impact of COVID-19, focusing on the gut microbiome offers a promising path forward. Supporting a balanced and diverse microbiome through diet, lifestyle, and targeted interventions like synbiotics may provide a natural way to strengthen immunity and improve health outcomes in both acute and long COVID cases.</jats:p>",
"alternative-id": [
"10.1177/17534259251362023"
],
"article-number": "17534259251362023",
"author": [
{
"ORCID": "https://orcid.org/0000-0002-7958-068X",
"affiliation": [
{
"name": "Department of Biochemistry, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia"
}
],
"authenticated-orcid": false,
"family": "Bajić",
"given": "Dejana",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia"
}
],
"family": "Todorović",
"given": "Nemanja",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia"
}
],
"family": "Popović",
"given": "Mladena Lalić",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Pediatrics, Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia"
}
],
"family": "Plazačić",
"given": "Milica",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Physiology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia"
}
],
"family": "Mihajlović",
"given": "Andrea",
"sequence": "additional"
}
],
"container-title": "Innate Immunity",
"container-title-short": "Innate Immun",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"journals.sagepub.com"
]
},
"created": {
"date-parts": [
[
2025,
7,
28
]
],
"date-time": "2025-07-28T07:00:08Z",
"timestamp": 1753686008000
},
"deposited": {
"date-parts": [
[
2025,
7,
31
]
],
"date-time": "2025-07-31T13:23:41Z",
"timestamp": 1753968221000
},
"indexed": {
"date-parts": [
[
2025,
8,
2
]
],
"date-time": "2025-08-02T19:42:23Z",
"timestamp": 1754163743763,
"version": "3.41.2"
},
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2025,
7
]
]
},
"language": "en",
"license": [
{
"URL": "https://journals.sagepub.com/page/policies/text-and-data-mining-license",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
7,
1
]
],
"date-time": "2025-07-01T00:00:00Z",
"timestamp": 1751328000000
}
}
],
"link": [
{
"URL": "https://journals.sagepub.com/doi/pdf/10.1177/17534259251362023",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://journals.sagepub.com/doi/full-xml/10.1177/17534259251362023",
"content-type": "application/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://journals.sagepub.com/doi/pdf/10.1177/17534259251362023",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "179",
"original-title": [],
"prefix": "10.1177",
"published": {
"date-parts": [
[
2025,
7
]
]
},
"published-online": {
"date-parts": [
[
2025,
7,
27
]
]
},
"published-print": {
"date-parts": [
[
2025,
7
]
]
},
"publisher": "SAGE Publications",
"reference": [
{
"DOI": "10.1093/pcmedi/pbae015",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_2_2"
},
{
"DOI": "10.1038/s41591-020-01202-8",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_3_2"
},
{
"DOI": "10.3390/diagnostics14070711",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_4_2"
},
{
"DOI": "10.1038/s41467-024-47720-8",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_5_2"
},
{
"article-title": "Long COVID: a global health issue - a prospective, cohort study set in four continents",
"author": "Pazukhina E",
"first-page": "1",
"journal-title": "BMJ Glob Heal",
"key": "e_1_3_2_6_2",
"unstructured": "Pazukhina E, Garcia-Gallo E, Reyes LF, et al. Long COVID: a global health issue - a prospective, cohort study set in four continents. BMJ Glob Heal 2024; 9: 1–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/39433402.",
"volume": "9",
"year": "2024"
},
{
"DOI": "10.1016/j.cell.2024.07.054",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_7_2"
},
{
"DOI": "10.3389/fimmu.2024.1341600",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_8_2"
},
{
"DOI": "10.3390/ijms242417198",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_9_2"
},
{
"DOI": "10.3389/fimmu.2020.01441",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_10_2"
},
{
"DOI": "10.1038/s41579-022-00846-2",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_11_2"
},
{
"DOI": "10.3389/fimmu.2024.1413485",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_12_2"
},
{
"DOI": "10.1080/19490976.2023.2247025",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_13_2"
},
{
"DOI": "10.3389/fmicb.2023.1244293",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_14_2"
},
{
"DOI": "10.3389/fimmu.2024.1536258",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_15_2"
},
{
"DOI": "10.3390/gastroent15030048",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_16_2"
},
{
"DOI": "10.1124/pharmrev.124.001202",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_17_2"
},
{
"article-title": "Influence of gut microbiota on autoimmunity: a narrative review",
"author": "Sai A",
"first-page": "100046",
"journal-title": "Brain Behav Immun Integr",
"key": "e_1_3_2_18_2",
"unstructured": "Sai A, Shetty GB, Shetty P HLN. Influence of gut microbiota on autoimmunity: a narrative review. Brain Behav Immun Integr 2024; 5: 100046.",
"volume": "5",
"year": "2024"
},
{
"DOI": "10.1016/j.jff.2025.106660",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_19_2"
},
{
"DOI": "10.1016/j.lfs.2024.123153",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_20_2"
},
{
"DOI": "10.1038/s41385-021-00389-4",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_21_2"
},
{
"DOI": "10.1146/annurev-immunol-090222-102035",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_22_2"
},
{
"DOI": "10.1136/gutjnl-2024-333378",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_23_2"
},
{
"DOI": "10.3389/fimmu.2019.01203",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_24_2"
},
{
"DOI": "10.1093/gerona/glae045",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_25_2"
},
{
"DOI": "10.1038/s12276-023-01088-9",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_26_2"
},
{
"DOI": "10.3390/microorganisms12020234",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_27_2"
},
{
"DOI": "10.3121/cmr.2024.1865",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_28_2"
},
{
"DOI": "10.4049/jimmunol.2300480",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_29_2"
},
{
"DOI": "10.3390/metabo12100912",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_30_2"
},
{
"DOI": "10.1111/jgh.15796",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_31_2"
},
{
"DOI": "10.3390/microorganisms12071443",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_32_2"
},
{
"DOI": "10.1002/jmv.28463",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_33_2"
},
{
"DOI": "10.1002/fsn3.4142",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_34_2"
},
{
"DOI": "10.1038/s41586-020-2700-3",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_35_2"
},
{
"DOI": "10.1016/j.arr.2022.101818",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_36_2"
},
{
"article-title": "Immunological dysfunction and mast cell activation syndrome in long COVID",
"author": "Sumantri S",
"first-page": "50",
"journal-title": "Asia Pac Allergy",
"key": "e_1_3_2_37_2",
"unstructured": "Sumantri S, Rengganis I. Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac Allergy 2023; 13: 50–53.",
"volume": "13",
"year": "2023"
},
{
"article-title": "Connecting the dots in emerging mast cell research: do factors affecting mast cell activation provide a missing link between adverse COVID-19 outcomes and the social determinants of health?",
"author": "Silveira Gorman R",
"first-page": "29",
"journal-title": "Med Sci (Basel, Switzerland)",
"key": "e_1_3_2_38_2",
"unstructured": "Silveira Gorman R, Syed IU. Connecting the dots in emerging mast cell research: do factors affecting mast cell activation provide a missing link between adverse COVID-19 outcomes and the social determinants of health? Med Sci (Basel, Switzerland) 2022; 10: 29.",
"volume": "10",
"year": "2022"
},
{
"DOI": "10.1007/s10787-024-01578-w",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_39_2"
},
{
"DOI": "10.1111/bph.15206",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_40_2"
},
{
"DOI": "10.3390/jox12040020",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_41_2"
},
{
"DOI": "10.1038/s41598-024-71264-y",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_42_2"
},
{
"DOI": "10.3390/biom12101443",
"doi-asserted-by": "publisher",
"key": "e_1_3_2_43_2"
}
],
"reference-count": 42,
"references-count": 42,
"relation": {},
"resource": {
"primary": {
"URL": "https://journals.sagepub.com/doi/10.1177/17534259251362023"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Immunity's core reset: Synbiotics and gut microbiota in the COVID-19 era",
"type": "journal-article",
"update-policy": "https://doi.org/10.1177/sage-journals-update-policy",
"volume": "31"
}
